✦ LIBER ✦

Inhibition of STAT3 Enhances the Radiosensitizing Effect of Temozolomide in Malignant Glioma Cells

✍ Scribed by Kim, I.; Choi, E.; Cho, B.

Book ID: 123147613
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 48 KB
Volume: 87
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2013.06.1713

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhancement of the Radiosensitizing Effe

Enhancement of the Radiosensitizing Effect of Temozolomide: Targeting EGFR-associated Signaling in Malignant Glioma Cells

✍ Kim, I.; Choi, E.; Cho, B.; Lee, D.J.; Wu, H.; Kim, J.; Kim, I. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

915 POSTER Enhancement of glioma cell li

915 POSTER Enhancement of glioma cell line radiosensitivity by the DNA methylating agent Temozolomide

✍ W.J. Kil; D. Cerna; W.E. Burgan; K. Beam; D. Carter; P. Tofilon; S. Ohta; K. Cam 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Inhibition of c-Jun N-terminal kinase en

Inhibition of c-Jun N-terminal kinase enhances temozolomide-induced cytotoxicity in human glioma cells

✍ Shigeo Ohba; Yuichi Hirose; Takeshi Kawase; Hirotoshi Sano 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 384 KB

Inhibition of Aurora kinases enhances ch

Inhibition of Aurora kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells

✍ Kleiton Silva Borges; Angel Maurício Castro-Gamero; Daniel Antunes Moreno; Vanes 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 535 KB

Inhibition of STAT-3 results in radiosen

Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma

✍ James A. Bonner; Hoa Q. Trummell; Christopher D. Willey; Brian A. Plants; Kevin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 457 KB

Temozolomide in the treatment of recurre

Temozolomide in the treatment of recurrent malignant glioma

✍ Susan M. Chang; Philip Theodosopoulos; Kathleen Lamborn; Mary Malec; Jane Rabbit 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract ## BACKGROUND Options for chemotherapy at the time of recurrence in patients with malignant glioma are limited. The authors describe the efficacy and safety results of their institution's open‐label, compassionate‐use protocol of temozolomide for patients with recurrent malignant gliom